Skip to main content
Search
Search
Advanced Search
Skip main navigation
Open access
Research Article
28 November 2025

Iron deficiency treatment pathway in Italy: patients’ perceptions of diagnosis and treatment

Authors: Ovidio Brignoli, Rose-Marie Carneiro, Cécile Fournier, Ettore Pinardi, and Maurizio Serati [email protected]Author Info & Affiliations
Volume 14, Number 12
https://doi.org/10.57264/cer-2025-0011
PDFFormats

Abstract

Aim: This 2023 online survey assessed the management of patients with iron deficiency anemia/iron deficiency without anemia (IDA/IDWA) in Italy. Materials & methods: The study used the patient’s perspective to examine care pathways used to manage IDA/IDWA in Italy, to raise clinician awareness, improve patient care (earlier diagnosis, initiate appropriate treatment) and outcomes (reduce recurrence/progression). The survey questioned iron deficiency (ID) diagnoses of patients, their sources of information and influence, their knowledge of ID, perceptions and fears surrounding treatment, unmet needs and expectations, and underlying causes of treatment compliance and persistence. Results: Of the 404 respondents (102 males and 302 females) who completed the survey, all were aged between 18 and 80 years. Almost all respondents (97.0%) experienced ID symptoms, most frequently fatigue, weakness and tiredness (71.0% of the total cohort; 80.1% females vs 44.1% males); 76.8% of all respondents regarded symptoms as ‘bothersome’. Most respondents (70.5%) consulted a physician as the first action to treat ID (79.8% females vs 43.1% males); general practitioners were the main healthcare providers, consulted by 55.6% of all respondents. Most respondents (94.1%) were aware of potential ID recurrence, and 75.0% reported recurrent ID episodes since their diagnosis. Satisfaction with ID treatment was rated as average (7–7.7/10); 56.4% of all respondents stayed on ID treatment for as long as prescribed, and 41.1% did not fully comply with tablet intake, primarily because they ‘felt much better’ (64.8%). Conclusion: This survey identified high rates of self-reported ID symptoms and recurrent ID episodes among respondents. It highlights the importance of increasing awareness of ID and its consequences among healthcare practitioners and individuals in the general population, of shortening the time before diagnosis, and ensuring that patients continue treatment for the prescribed duration to resaturate serum iron levels.

Plain language summary

What is this article about?

Iron deficiency (ID) is a condition in which a person does not have enough iron in their body to maintain adequate levels of healthy red blood cells, for reasons such as heavy menstrual bleeding, low dietary iron intake or poor iron absorption. ID often leads to anemia, when there are not enough healthy red blood cells carrying oxygen throughout the body. Iron deficiency anemia (IDA) is very common, as is iron deficiency without anemia (IDWA). Untreated IDA can lead to severe health problems, including extreme fatigue, weakness, hair loss and rapid heart rate, so the proper management of IDA is important. Diagnosing IDA and IDWA is complicated by inadequate screening recommendations, a lack of awareness of IDWA among healthcare practitioners (HCPs), and the clinical signs and symptoms of ID are often ignored. HCPs also differ widely in their choice of iron compounds for managing IDA and IDWA. This paper describes findings from a survey among adults in Italy diagnosed with IDA or IDWA and treated in the past 12 months with prescription medication.

What were the results?

Most survey respondents did not know their ID status prior to diagnosis and after receiving an ID treatment the main reason for no compliance was because the patient felt better.

Why is this important?

The findings suggest that both HCPs and the general population need to be more aware of ID and its consequences, and how to manage ID. HCPs can play a vital role in educating and supporting patients on ID treatment, to improve their understanding about managing their disease and continuing treatment for as long as is needed.

Shareable abstract

A survey in 404 Italian patients with iron deficiency shows that almost half do not take their oral iron treatment as prescribed. Yet 75% have recurrent episodes of iron deficiency.
#iron deficiency #anemia #iron treatment #patient perspectives #compliance

Supplementary Material

File (supplementary materials.docx)

References

Papers of special note have been highlighted as: •• of considerable interest
1.
Al-Naseem A, Sallam A, Choudhury S, Thachil J. Iron deficiency without anaemia: a diagnosis that matters. Clin. Med. (Lond.) 21(2), 107–113 (2021).
PubMed
Google Scholar
•• Considers the causes and clinical features of iron deficiency without anemia, calls for greater awareness of the condition and proposes diagnostic and management algorithms.
2.
Camaschella C. Iron deficiency. Blood 133(1), 30–39 (2019).
PubMed
Google Scholar
3.
Kumar A, Sharma E, Marley A, Samaan MA, Brookes MJ. Iron deficiency anaemia: pathophysiology, assessment, practical management. BMJ Open Gastroenterol. 9(1), e000759 (2022).
Google Scholar
•• Discusses the diagnosis and management of iron deficiency anemia in patients with chronic conditions, preoperative and in pregnancy, as well as the benefits and limitations of oral versus intravenous iron replacement in each cohort.
4.
Serati M, Espuna-Pons M, Mouton-Puglisi A, Padoa A. Iron deficiency and sexual dysfunction in women. Sex. Med. Rev. 11(4), 342–348 (2023).
PubMed
Google Scholar
5.
Peuranpaa P, Heliovaara-Peippo S, Fraser I, Paavonen J, Hurskainen R. Effects of anemia and iron deficiency on quality of life in women with heavy menstrual bleeding. Acta Obstet. Gynecol. Scand. 93(7), 654–660 (2014).
PubMed
Google Scholar
6.
Brignoli O. Anemia and iron therapy [in Italian]; data from Health Search - Italian Society of General Medicine, Symposium Highlights - Speaker: Adriana Masotti; SIMG National Congress 2012. J. Ital. Soc. Gen. Med. 4, 33–37 (2013).
Google Scholar
7.
Akpan IJ, Narang M, Zampaglione E, Marshall S, Stefanik D. Iron deficiency anemia in patients with heavy menstrual bleeding: the patients' perspective from diagnosis to treatment. Womens Health (Lond) 21, 17455057251321221 (2025).
Google Scholar
8.
Danese S, Gisbert JP, Lobo AJ et al. Patient and physician perspectives in managing iron deficiency with or without anaemia in inflammatory bowel disease: findings from a European online survey. J. Crohn's Colitis 11, S244 (2017).
Google Scholar
9.
Robalo Nunes A, Mairos J, Brilhante D et al. Screening for anemia and iron deficiency in the adult Portuguese population. Anemia 2020, 1048283 (2020).
PubMed
Google Scholar
10.
Weyand AC, Chaitoff A, Freed GL, Sholzberg M, Choi SW, McGann PT. Prevalence of iron deficiency and iron-deficiency anemia in US females aged 12–21 years, 2003–2020. JAMA 329(24), 2191–2193 (2023).
PubMed
Google Scholar
11.
Grandy S, Palaka E, Guzman N, Dunn A, Wittbrodt ET, Finkelstein FO. Understanding patient perspectives of the impact of anemia in chronic kidney disease: a United States patient survey. J. Patient Exp. 9, 23743735221092629 (2022).
Google Scholar
12.
Hao CM, Wittbrodt ET, Palaka E, Guzman N, Dunn A, Grandy S. Understanding patient perspectives and awareness of the impact and treatment of anemia with chronic kidney disease: a patient survey in China. Int. J. Nephrol. Renovasc. Dis. 14, 53–64 (2021).
PubMed
Google Scholar
13.
Iolascon A, Andolfo I, Russo R et al. Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia. Hemasphere 8(7), e108 (2024).
PubMed
Google Scholar
•• Presents the recommendations from the European Hematology Association about screening, diagnosis and treatment of iron deficiency.
14.
Lopez-Garcia YK, Colunga-Pedraza PR, Tarin-Arzaga L, Lopez Garza MI, Jaime-Perez JC, Gomez-Almaguer D. Iron deficiency anemia referral to the hematologist. Real-world data from Mexico: the need for targeted teaching in primary care. Hematology 23(9), 658–663 (2018).
PubMed
Google Scholar
15.
Dugan C, MacLean B, Cabolis K et al. The misogyny of iron deficiency. Anaesthesia 76(Suppl. 4), 56–62 (2021).
PubMed
Google Scholar
16.
Galdas PM, Cheater F, Marshall P. Men and health help-seeking behaviour: literature review. J. Adv. Nurs. 49(6), 616–623 (2005).
PubMed
Google Scholar
17.
Osika Friberg I, Krantz G, Maatta S, Jarbrink K. Sex differences in health care consumption in Sweden: a register-based cross-sectional study. Scand. J. Public Health 44(3), 264–273 (2016).
PubMed
Google Scholar
18.
Simons K, Bradfield O, Spittal MJ, King T. Age and gender patterns in health service utilisation: age-period-cohort modelling of linked health service usage records. BMC Health Serv. Res. 23(1), 480 (2023).
PubMed
Google Scholar
19.
O'Brien R, Hunt K, Hart G. ‘It's caveman stuff, but that is to a certain extent how guys still operate’: men's accounts of masculinity and help seeking. Soc. Sci. Med. 61(3), 503–516 (2005).
PubMed
Google Scholar
20.
Cromme SK, Whitaker KL, Winstanley K, Renzi C, Smith CF, Wardle J. Worrying about wasting GP time as a barrier to help-seeking: a community-based, qualitative study. Br. J. Gen. Pract. 66(648), e474–482 (2016).
PubMed
Google Scholar
21.
Selvi Oztorun H, Cinar E, Turgut T et al. The impact of treatment for iron deficiency and iron deficiency anemia on nutritional status, physical performance, and cognitive function in geriatric patients. Eur. Geriatr. Med. 9(4), 493–500 (2018).
PubMed
Google Scholar
22.
Marcus H, Schauer C, Zlotkin S. Effect of anemia on work productivity in both labor- and nonlabor-intensive occupations: a systematic narrative synthesis. Food Nutr. Bull. 42(2), 289–308 (2021).
PubMed
Google Scholar
23.
World Health Organisation. Iron deficiency anaemia – assessment, prevention and control. A guide for programme managers. WHO/NHD/01.3; (2001). Available from: https://cdn.who.int/media/docs/default-source/2021-dha-docs/ida_assessment_prevention_control.pdf (Accessed: 30 January 2025).
Google Scholar
|